Holders — by stockHoldings — by fund
Checkpoint Capital L.P.
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001977548
$442.3M
disclosed book value
8
positions
39.3%
largest position share
Positions, as of 2026-09-30
top 8 of 8 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | ARGXARGENX SE | 181,500 | $174.0M | 39.3% |
| 2 | RYTMRHYTHM PHARMACEUTICALS INC | 1.2M | $115.8M | 26.2% |
| 3 | RVMDREVOLUTION MEDICINES INC | 422,911 | $86.8M | 19.6% |
| 4 | CYTKCYTOKINETICS INC | 517,278 | $34.1M | 7.7% |
| 5 | IRONDISC MEDICINE INC | 399,830 | $26.2M | 5.9% |
| 6 | SEPNSEPTERNA INC | 64,000 | $2.5M | 0.6% |
| 7 | TRVITREVI THERAPEUTICS INC | 137,000 | $2.0M | 0.4% |
| 8 | OCSOCULIS HOLDING AG | 99,500 | $929,330 | 0.2% |
Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.